The primary treatments for AD with proven efficacy are the acetylcholinesterase inhibitors that prevent acethylcoline degradation and prolong its activity in synapses, although their insufficient efficacy and marginal tolerability has limited their clinical utility over the years. Here, ACHE is linked to Alzheimer disease.